PDB37 MEALTIME INSULIN ASPART REDUCES THE LONG-TERM COST OF COMPLICATIONS COMPARED TO HUMAN INSULIN AS PART OF BASAL-BOLUS THERAPY IN POLISH TYPE 2 DIABETES PATIENTS
Abstract
Authors
G Goodall S Nielsen C Townsend R Kotchie K Erny-Albrecht WJ Valentine